[1]
GANNA, S. et al. 2021. OPTIMIZATION AND CHARACTERIZATION OF RIVASTIGMINE-LOADED NANOSTRUCTURED LIPID CARRIERS. International Journal of Current Pharmaceutical Research. 13, 3 (May 2021), 46–51. DOI:https://doi.org/10.22159/ijcpr.2021v13i3.42093.